Alpha 4 integrin blockade in inflammatory bowel disease.
Ghosh
S
S
Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, UK. s.ghosh@ic.ac.uk
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology; D039441:Integrin alpha4 / Q000276:immunology*; D000069442:Natalizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; D000069442:Natalizumab; D039441:Integrin alpha4